A Study of CAT-1004 Biomarkers in Healthy Subjects

Clinical trial NCT01670773 · COMPLETED

Trial details

NCT number: NCT01670773
Sponsor: Catabasis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Assessment of Mechanistic Blood Biomarkers in Healthy Humans

Start date: 2012-08-01
Primary completion: 2012-10-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.